Richmond Hill, Canada Clinical Trials

A listing of Richmond Hill, Canada clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 44 clinical trials
A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes

This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medicine). The study will be performed in people with type 2 diabetes. Participants will either get semaglutide or placebo in addition to their diabetes medicines - which treatment the …

semaglutide
hypoglycemic agents
Novo Nordisk Investigational Site
 (6.8 away) Contact site
  • 581 views
  • 22 Sep, 2021
  • +237 other locations
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata

The overall objectives of the study are to evaluate long-term safety of CTP-543 and to assess long-term effects of CTP-543 on treating hair loss in adult patients with chronic, moderate to severe alopecia areata.

alopecia
areata alopecia
Lynderm Research Inc.
 (8.9 away) Contact site
  • 476 views
  • 22 Sep, 2021
  • +47 other locations
An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease

This study seeks to evaluate the safety and efficacy of brazikumab versus placebo (Stage I) and versus an active comparator (Stage 2) in participants with moderately to severely active CD and will include assessments of clinical response as demonstrated by improvement of symptoms and colonic mucosal appearance as observed on …

aminosalicylate
antibiotics
crohn's disease
mercaptopurine
azathioprine
Toronto Digestive Disease Associates Inc
 (9.6 away) Contact site
  • 400 views
  • 20 Sep, 2021
  • +320 other locations
A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis

The purpose of this study is to evaluate the efficacy and safety of mirikizumab as maintenance therapy in participants who completed prior 12-week induction study AMAN (NCT03518086).

mirikizumab
endoscopy
Toronto Digestive Disease Associates, Inc.
 (9.6 away) Contact site
  • 386 views
  • 22 Sep, 2021
  • +912 other locations
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)

The purpose of this study is to evaluate the safety and efficacy of Mirikizumab in participants with moderately to severely active ulcerative colitis (UC) who have had an inadequate response to, loss of response, or intolerant to conventional or biologic therapy for UC.

mirikizumab
Toronto Digestive Disease Associates, Inc.
 (9.6 away) Contact site
  • 1735 views
  • 22 Sep, 2021
  • +880 other locations
A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)

The purpose of this study is to evaluate the long-term safety and maintenance of efficacy of mirikizumab in participants with moderate-to-severe plaque psoriasis.

mirikizumab
plaque psoriasis
Lynderm Research Inc
 (8.9 away) Contact site
  • 717 views
  • 22 Sep, 2021
  • +361 other locations
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increased cardiovascular risk.

hemoglobin a1c
body mass index
cardiovascular disease
LMC Endocrinology Centres Ltd.
 (6.8 away) Contact site
  • 597 views
  • 22 Sep, 2021
  • +895 other locations
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease. Additional participants will be enrolled to an addendum safety cohort. The participants will be administered open-label donanemab.

mini-mental state examination
florbetapir
flortaucipir
alzheimer's disease
positron emission tomography
Toronto Memory Program
 (9.6 away) Contact site
  • 89 views
  • 17 Sep, 2021
  • +394 other locations
Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)

This 110-week study is designed to assess the long-term safety and efficacy of lebrikizumab for moderate-to-severe atopic dermatitis.

atopy
lebrikizumab
eczema
progestogen
topical agents
The Centre for Dermatology
 (3.5 away) Contact site
  • 154 views
  • 22 Sep, 2021
  • +357 other locations
PN-943 in Adults With Moderate to Severe Active Ulcerative Colitis (UC)

The purpose of the study is to evaluate the safety, tolerability, and clinical efficacy of PN-943 450 mg twice daily [BID] and PN-943 150 mg BID, compared with placebo BID, in subjects with moderate to severe active Ulcerative Colitis (UC).

Protagonist Investigational Site
 (9.6 away) Contact site
  • 0 views
  • 21 Sep, 2021
  • +87 other locations